Hing Sham - Net Worth and Insider Trading

Hing Sham Net Worth

The estimated net worth of Hing Sham is at least $3 Million dollars as of 2025-03-26. Hing Sham is the SVP of Chemistry of Global Blood Therapeutics Inc and owns about 36,775 shares of Global Blood Therapeutics Inc (GBT) stock worth over $3 Million. Details can be seen in Hing Sham's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Hing Sham has not made any transactions after 2015-08-17 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

GuruFocus Premium Membership
30 Years of Financial Data
Unlimited Filters in All-in-One Stock Screener
Earnings Calls & Stock Analysis
Customizable Stock Dashboard
Real-Time Insider Trading Alerts
8,000+ Institutional Investors’ 13F Holdings
Excel & Google Sheets Integration
Quick Customer Support
And Much More...

Transaction Summary of Hing Sham

To

Hing Sham Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Hing Sham owns 1 companies in total, including Global Blood Therapeutics Inc (GBT) .

Click here to see the complete history of Hing Sham’s form 4 insider trades.

Insider Ownership Summary of Hing Sham

Ticker Comapny Transaction Date Type of Owner
GBT Global Blood Therapeutics Inc 2015-08-17 See Remarks

Hing Sham Latest Holdings Summary

Hing Sham currently owns a total of 1 stock. Hing Sham owns 36,775 shares of Global Blood Therapeutics Inc (GBT) as of August 17, 2015, with a value of $3 Million.

Latest Holdings of Hing Sham

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
GBT Global Blood Therapeutics Inc 2015-08-17 36,775 68.49 2,518,720

Holding Weightings of Hing Sham


Hing Sham Form 4 Trading Tracker

According to the SEC Form 4 filings, Hing Sham has made a total of 0 transactions in Global Blood Therapeutics Inc (GBT) over the past 5 years. The most-recent trade in Global Blood Therapeutics Inc is the acquisition of 2,000 shares on August 17, 2015, which cost Hing Sham around $40,000.

Insider Trading History of Hing Sham

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Hing Sham Trading Performance

GuruFocus tracks the stock performance after each of Hing Sham's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Hing Sham is -12.39%. GuruFocus also compares Hing Sham's trading performance to market benchmark return within the same time period. The performance of stocks bought by Hing Sham within 3 months outperforms 0 times out of 1 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Hing Sham's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Hing Sham

Average Return

LIMIT
Average return per transaction

Outperforming Transactions

LIMIT
0 out of 1 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) -2.47 LIMIT LIMIT LIMIT LIMIT LIMIT
Relative Return to S&P 500(%) 2.87 LIMIT LIMIT LIMIT LIMIT LIMIT

Hing Sham Ownership Network

Ownership Network List of Hing Sham

No Data

Ownership Network Relation of Hing Sham

Insider Network Chart

Hing Sham Owned Company Details

What does Global Blood Therapeutics Inc do?

Who are the key executives at Global Blood Therapeutics Inc?

Hing Sham is the See Remarks of Global Blood Therapeutics Inc. Other key executives at Global Blood Therapeutics Inc include Chief Financial Officer Jeffrey S Farrow , See Remarks Nazila Habibizad , and Chief Human Resources Officer Carrie Krehlik .

Global Blood Therapeutics Inc (GBT) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Global Blood Therapeutics Inc (GBT) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Global Blood Therapeutics Inc (GBT) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Global Blood Therapeutics Inc (GBT)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Global Blood Therapeutics Inc Insider Transactions

No Available Data

Hing Sham Mailing Address

Above is the net worth, insider trading, and ownership report for Hing Sham. Based on the public information released on the U.S. Securities and Exchange Commission (SEC) website, Hing Sham's mailing address is: Suite 101 South San Francisco Ca 94080.